Worldwide IVD Market Procedure and Pricing Analysis Report 2017 - Research and Markets

DUBLIN, Apr. 13, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Worldwide IVD Market: Procedure and Pricing Analysis" report to their offering.

According to this latest study on the in vitro diagnostic industry, the global volume of IVD procedures is forecast to increase 2.7 percent annually to over 24 billion in 2021. New companies enter the IVD market on a consistent basis, and IVD market revenue growth exceeds device or average pharmaceutical markets. This report focuses on procedure volumes.

Worldwide IVD Market: Procedure Volume and Pricing Analysis examines global trends in the volume of IVD procedures conducted in clinical laboratories and at point-of-care sites. Aging population trends and a rising level of diseases and disorders will boost the volume of patient testing conducted in most countries.

The adaptation of molecular and other advanced life science technologies to new and improved reagents and instruments will broaden IVD capabilities in detecting medical conditions. Medical providers throughout the world will rely increasingly on point-of-care (POC) and clinical laboratory tests to identify patient health problems in early stages and prescribe appropriate therapies.

Worldwide In Vitro Diagnostic Market: Procedure Volumes and Pricing Analysis includes the following data points

- Worldwide IVD Market, 2016-2021
- Point-of Care-Procedures, 2016-2021
- Poin-of-Caare-Average Pricing
- Clinical Chemistry Procedures, 2016-2021
- Clinical Chemistry Average Pricing
- Molecular Procedures by type, 2016-2021
- Molecular Test Average Pricing
- Hematology Test Procedures, 2016-2021
- Hematology Test Procedure Average Pricing
- Coagulation Test Procedures, 2016-2021
- Coagulation Test Average Pricing
- Microbiology Test Procedures, 2016-2021
- Microbiology Test Average Pricing
- Blood Screening Test Procedures, 2016-2021
- Blood Screening Average Pricing
- Histology/Cytology Test Procedures, 2016-2021
- Histology/Cytology Average Pricing

Key Topics Covered:

1: Executive Summary

2: Introduction

3: Regional Market Procedure Volume Analysis

4: Point Of Care Testing

5: Core Laboratory Testing

6: Molecular Assays

7: Hematology

8: Coagulation

9: Microbiology

10: Blood Grouping

11: Histology And Cytology

12: Corporate Profiles And Company Procedure Volume Shares

13: Other IVD Competitors

Companies Mentioned

• Abbott Laboratories  
• Agilent Technologies
• Alere  
• Becton, Dickinson And Company  
• Bio-Rad Laboratories  
• Biomérieux  
• Danaher  
• Diasorin
• ERBA Diagnostics
• Eiken Chemical Company
• Fujirebio Diagnostics
• Hologic  
• Illumina
• Labcorp, Laboratory Corporation of America
• Luminex Corporation
• Menarini Diagnostics
• Mindray Medical
• Myriad Genetics
• Ortho Clinical Diagnostics  
• Perkin Elmer
• Qiagen N.V.
• Quest Diagnosticsn
• Quidel Corporatio
• Randox Laboratories
• Roche
• Royal Philips
• Siemens AG  
• Sysmex  
• Thermo Fisher Scientific
• Tosoh Corporation
• Trinity Biotech
• Wako Pure Chemical Industries

For more information about this report visit http://www.researchandmarkets.com/research/85h374/worldwide_ivd

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com